Announcements Trials

Browse Landscape Eligibility

Clinical Trials

0 trials

Recent Start date Enrollment

Anemia, Aplastic × Cyclosporine × 90 days × Clear all

Sponsor

Conditions

Leukemia, Myeloid, Acute 5 Precursor Cell Lymphoblastic Leukemia-Lymphoma 4 Myelodysplastic Syndromes 4 Lymphoma, Mantle-Cell 3 Lymphoma, Large B-Cell, Diffuse 3 Lymphoma, Follicular 3 Lymphoma, Non-Hodgkin 2 Lymphoma, B-Cell, Marginal Zone 2 Leukemia, Prolymphocytic 2 Leukemia, Myelomonocytic, Chronic 2 Leukemia, Myelogenous, Chronic, BCR-ABL Positive 2 Leukemia, Lymphocytic, Chronic, B-Cell 2 Leukemia, Biphenotypic, Acute 2 Burkitt Lymphoma 2 Recurrence 1 Primary Myelofibrosis 1 Myeloproliferative Disorders 1 Multiple Myeloma 1 Lymphoma, Large-Cell, Anaplastic 1 Leukemia, Plasma Cell 1 Leukemia, Myeloid, Chronic-Phase 1 Leukemia, Myeloid, Accelerated Phase 1 Leukemia, Monocytic, Acute 1 Leukemia, Lymphoid 1 Hodgkin Disease 1 Hematologic Diseases 1 Graft vs Host Disease 1 Blast Crisis 1 Anemia, Refractory, with Excess of Blasts 1

Interventions

Valganciclovir 1 Therapeutics 1 Polymerase Chain Reaction 1 Ganciclovir 1 Foscarnet 1 Flow Cytometry 1 Antiviral Agents 1 11-(2-pyrrolidin-1-ylethoxy)-14,19-dioxa-5,7,26-triazatetracyclo(19.3.1.1(2,6).1(8,12))heptacosa-1(25),2(26),3,5,8,10,12(27),16,21,23-decaene 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

No trials found.

Data powered by HemOnc (CC BY 4.0) Colophon ⚡